Does botulinum toxin treatment improve upper limb active function?
- PMID: 29960017
- DOI: 10.1016/j.rehab.2018.05.1320
Does botulinum toxin treatment improve upper limb active function?
Abstract
Background: Spasticity following lesions of the central nervous system such as stroke is a major cause of impairment and disability, especially when it affects the upper limb, and can be focally relieved by intramuscular injections of botulinum toxin (BT). Functional improvements of the affected upper limb after a BT focal treatment remain controversial.
Objective: We aimed to assess the functional effects of BT treatment on upper-limb spasticity in the literature, identify flaws and deficiencies in proving these effects and propose leads for future trials.
Methods: We searched the MEDLINE and Cochrane databases for trials, reviews and meta-analyses assessing the effect of BT injection in upper-limb spasticity. This was a non-systematic narrative review, and the selection of articles was based on the authors' expertise. The review focused on stroke-related spasticity and disability.
Results: Patients' therapeutic targets involved use of the disability assessment scale (DAS) or goal attainment scale (GAS). Impairments and passive function goals prevailed for active function and participation and were more frequently achieved for the former than the latter. Meta-analyses showed no to mild effect sizes for improvement in upper-limb function but failed to show higher and/or better use of the paretic upper limb in activities of daily living after BT injection.
Conclusion: BT injections for impairment and passive function are related to improved kinematic parameters; however, the relation between relief of spasticity and improved upper-limb activity has not been established. Possible explanations for the lack of functional effect in studies are first, disability is mainly due to muscle weakness rather than spasticity, so patients with the best underlying motricity may benefit the most from BT injections; second, assessment methods may not be adapted to screen eligible patients; third, most studies' endpoints were at 4 to 12 weeks after a single injection, but repeated treatment sessions might be needed to observe functional outcome on the upper limbs; and finally, the association of rehabilitation programs or non-pharmacological treatments may enhance the functional effects of BT injections.
Keywords: Botulinum toxin; Outcome; Rehabilitation; Spasticity; Stroke; Upper limb.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260. Health Technol Assess. 2010. PMID: 20515600 Clinical Trial.
-
Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.Eur J Phys Rehabil Med. 2018 Oct;54(5):738-744. doi: 10.23736/S1973-9087.18.05086-4. Epub 2018 Feb 7. Eur J Phys Rehabil Med. 2018. PMID: 29422486
-
[Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):39-48. doi: 10.17116/jnevro202112111139. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34932284 Russian.
-
Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. J Neural Transm (Vienna). 2009. PMID: 19142573 Review.
-
Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.Drug Saf. 2006;29(1):31-48. doi: 10.2165/00002018-200629010-00003. Drug Saf. 2006. PMID: 16454533 Review.
Cited by
-
Non-invasive treatment of patients with upper extremity spasticity following stroke using paired trans-spinal and peripheral direct current stimulation.Bioelectron Med. 2019 Jul 23;5:11. doi: 10.1186/s42234-019-0028-9. eCollection 2019. Bioelectron Med. 2019. PMID: 32232101 Free PMC article.
-
Can Incobotulinumtoxin-A Treatment Improve Quality of Life Better Than Conventional Therapy in Spastic Muscle Post-Stroke Patients? Results from a Pilot Study from a Single Center.Brain Sci. 2021 Jul 15;11(7):934. doi: 10.3390/brainsci11070934. Brain Sci. 2021. PMID: 34356168 Free PMC article.
-
The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.Toxins (Basel). 2020 Jul 31;12(8):492. doi: 10.3390/toxins12080492. Toxins (Basel). 2020. PMID: 32751970 Free PMC article. Clinical Trial.
-
Neurophysiological and clinical outcome measures of the impact of electrical stimulation on spasticity in spinal cord injury: Systematic review and meta-analysis.Front Rehabil Sci. 2022 Dec 16;3:1058663. doi: 10.3389/fresc.2022.1058663. eCollection 2022. Front Rehabil Sci. 2022. PMID: 36589715 Free PMC article. Review.
-
Predictors of Clinically Important Improvements in Motor Function and Daily Use of Affected Arm after a Botulinum Toxin A Injection in Patients with Chronic Stroke.Toxins (Basel). 2021 Dec 23;14(1):13. doi: 10.3390/toxins14010013. Toxins (Basel). 2021. PMID: 35050990 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical